1. Comprehensive review of autoantibodies in patients with hyper-IgM syndrome
- Author
-
Barbouche, M, Chen, Q, Carbone, M, Ben-Mustapha, I, Shums, Z, Trifa, M, Malinverno, F, Bernuzzi, F, Zhang, H, Agrebi, N, Norman, G, Chang, C, Gershwin, M, Invernizzi, P, Barbouche, Mohamed-Ridha, Chen, Qubo, Carbone, Marco, Ben-Mustapha, Imen, Shums, Zakera, Trifa, Mehdi, Malinverno, Federica, Bernuzzi, Francesca, Zhang, Haiyan, Agrebi, Nourhen, Norman, Gary L, Chang, Christopher, Gershwin, M Eric, Invernizzi, Pietro, Barbouche, M, Chen, Q, Carbone, M, Ben-Mustapha, I, Shums, Z, Trifa, M, Malinverno, F, Bernuzzi, F, Zhang, H, Agrebi, N, Norman, G, Chang, C, Gershwin, M, Invernizzi, P, Barbouche, Mohamed-Ridha, Chen, Qubo, Carbone, Marco, Ben-Mustapha, Imen, Shums, Zakera, Trifa, Mehdi, Malinverno, Federica, Bernuzzi, Francesca, Zhang, Haiyan, Agrebi, Nourhen, Norman, Gary L, Chang, Christopher, Gershwin, M Eric, and Invernizzi, Pietro
- Abstract
Hyper-immunoglobulin M syndrome is an X-linked primary immunodeficiency disease caused by mutations in the CD40 ligand gene. The CD40 ligand has been recently highlighted as playing a key role in the pathogenesis of primary biliary cholangitis. In the present study, we assessed an extensive set of serum autoantibodies in a series of well-defined patients with hyper-immunoglobulin M syndrome. Serum, liver-related and liver-not-related autoantibodies IgG, IgM and IgA were tested by ELISA and standard indirect immunofluorescence in HEp-2 cells in 13 Tunisian patients (8 males and 5 females, aged 1–12 years) with hyper-immunoglobulin M syndrome during 1995–2012 and, as controls, 21 age- and gender-matched blood donors. The level of IgM antibody against MIT3 was significantly higher in patients than in controls (35.8 vs 10.7, P=0.002). Half of the hyperimmunoglobulin M syndrome patients were found to be anti-MIT3 IgM positive vs none of the controls (P<0.0001). Twenty-three percent of patients were found to be anti-sp100 antibody positive vs only 0.05% of controls. By immunofluorescence, 92.3% of patients were MIT3 IgM positive vs none of the controls. In conclusion, the IgM class of anti-MIT3 antibodies was shown to be present by both ELISA and immunofluorescence in most of the patients with hyper-immunoglobulin M syndrome. The presence of the hallmark of primary biliary cholangitis, a disease where the CD40 ligand is a key player, in an immunodeficiency disease caused by mutations in the CD40 ligand gene is very intriguing and opens new scenarios in understanding the immune pathogenesis of primary biliary cholangitis.
- Published
- 2018